Kathryn Wheeler, PharmD, BCPS, is assistant clinical professor of pharmacy practice, University of Connecticut School of Pharmacy, Storrs, Conn.
New Treatment Approved for Menopausal Hot Flashes
Fezolinetant (Veozah) is approved for the treatment of moderate to severe vasomotor symptoms (ie, hot flashes and night sweats) related to menopause.
Oral Treatment Approved for Anemia Caused by CKD
Daprodustat increases erythropoietin production, leading to an increase in the production of red blood cells.
Novel, Dual-Targeted Treatment for T2D Is FDA Approved
Tirzepatide is a once-weekly subcutaneous injection to treat type 2 diabetes in conjunction with diet and exercise.
FDA Approves Treatment for Uremic Pruritis
Korsuva is approved for treating moderate to severe pruritis associated with chronickidneydisease
Novel Antifungal Treatment Approved for Vaginal Candidiasis
On June 2,2021, ibrexafungerp (Brexafemme; Scynexis, Inc) was approved by the FDA for vulvovaginal candidiasis (VVC) in adult women and girls who have begun menstruating.
New Nonstimulant Medication Is Approved for ADHD in Children
Viloxazine is a selective norepinephrine reuptake inhibitor and is the first new nonstimulant medication for treatment of ADHD in children in more than 10 years.
New Drug Review: Voclosporin for Lupus Nephritis
Barhemsys (Amisulpride) for Postoperative Nausea and Vomiting
On February 27, 2020, the FDA approved an intravenous solution of amisulpride (Barhemsys; Acacia Pharma) to treat and prevent postoperative nausea and vomiting.
Lumateprone Tosylate Approved for Schizophrenia
The FDA has approved lumateperone tosylate (Caplyta™, Intra-Cellular Therapies) for treatment of schizophrenia in adults.
Ubrogepant: A Novel Drug Mechanism for Migraine Treatment
On December 23, 2019, the FDA approved ubrogepant for the acute treatment of migraine with and without aura in adult patients.
New Drug Review: Zulresso (Brexanolone)
The first drug approved to specifically treat post-partum depression.
Prucalopride Approved for Idiopathic Constipation
What you need to know about the serotonin-4 receptor agonist approved for adult patients.
New Drug Review: Dsuvia (Sufentanil) for Acute Refractory Pain
Sublingual form approved for short-term use.
What Pharmacists Need to Know About Erenumab-aooe
The latest New Drug Review covers Amgen’s migraine medication.
Avatrombopag for Thrombocytopenia in Adults
Our latest New Drug Review covers Dova’s most recent medication.
Ibalizumab-uiyk (Trogarzo) for Multi-Drug-Resistant HIV-1
What pharmacists need to know about the new antibody approved for multi-drug-resistant HIV-1.
First in Class Drug for Glaucoma: What Pharmacists Need to Know
Netarsudil opthalmis solution (Rhopressa, Aerie Pharmaceuticals), is approved by the FDA for treatment of elevated intraocular pressure in patients with open-angle glaucoma or ocular hypertension.
2 Clarke Drive Cranbury, NJ 08512